New treatment closer to cancer cure New York - Arabstoday Existing drugs offer new treatment options for a high-risk childhood leukemia subtype of the most common childhood cancer, U.S. researchers said. Dr. Charles Mullighan, an associate member of the St. Jude Children's Research Hospital Department of Pathology, said the discovery of the genetic basis of a high-risk subtype of leukemia showed some patients might benefit from existing targeted therapies, advancing the goal of curing all children with leukemia. The study focused on a subtype of acute lymphoblastic leukemia known as Philadelphia chromosome-like acute lymphoblastic leukemia, or Ph-like ALL, that accounted for as much as 15 percent of childhood acute lymphoblastic leukemia. It is associated with a high risk of relapse and poor outcomes. "One of the next steps will be to continue work on laboratory tests to rapidly identify patients whose cancer cells carry these alterations and to develop clinical trials to test targeted therapies," Mullighan said in a statement. The findings were published online in the journal Cancer Cell.
GMT 12:06 2018 Thursday ,13 December
Blue light in smartphones linked to blindness and some cancersGMT 11:56 2018 Friday ,30 November
Congo Ebola outbreak becomes second-worst in history, IRC saysGMT 17:52 2018 Sunday ,25 November
Russian medical team provides services to citizen in Talbiseh town in HomsGMT 11:26 2018 Thursday ,15 November
Cameroon strives to curb maternal and infant mortality in restive Anglophone regionsGMT 10:39 2018 Tuesday ,13 November
Emirati tourists warned against vaping, import of e-cigarettes into ThailandGMT 12:11 2018 Friday ,09 November
Conjoined Bhutanese twins separated by surgeons in AustraliaGMT 16:06 2018 Tuesday ,06 November
Drug-resistant bugs claim 33,000 lives a year in EuropeGMT 17:43 2018 Friday ,02 November
Study confirms cell phone radiation linked to cancer risks in male ratsMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Send your comments
Your comment as a visitor